Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Bortezomib: Understanding the Mechanism of Action

Bilal Piperdi, Yi-He Ling, Leonard Liebes, Franco Muggia, Roman Perez-Soler

Mol Cancer Ther (2011) 10 (11): 2029–2030.

https://doi.org/10.1158/1535-7163.MCT-11-0745

Published: 08 November 2011

View article titled, Bortezomib: Understanding the Mechanism of Action

Journal Articles

Abstract B235: The utility of TRC093; A humanized monoclonal antibody directed against cleaved collagen in the detection of patients at risk of ovarian and breast cancer

Leonard Liebes, Jennifer Lu, Ryan Pennell, Stephanie Blank, Tarah Pua, Franco Muggia, David Fishman, Charles Theuer, Jenn Roth, Peter Brooks

Mol Cancer Ther (2009) 8 (12_Supplement): B235.

https://doi.org/10.1158/1535-7163.TARG-09-B235

Published: 10 December 2009

View article titled, Abstract B235: The utility of TRC093; A humanized monoclonal antibody directed against cleaved collagen in the detection of patients at risk of ovarian and breast cancer

Journal Articles

Phase II trial of BAY 43-9006 (sorafenib-BAY) in metastatic melanoma (MM) including detection of BRAF mutations with mutant specific-PCR (MS-PCR) and altered proliferation pathways.

Christina Min, Leonard Liebes, Peter Brooks, Joanne Yoon, Herman Yee, Anne Hamilton, Michael Buckley, John Wright, Iman Osman, Franco Muggia, Anna Pavlick

Mol Cancer Ther (2007) 6 (11_Supplement): B254.

Published: 01 November 2007

View article titled, Phase II trial of BAY 43-9006 (sorafenib-BAY) in metastatic melanoma (MM) including detection of BRAF mutations with mutant specific-PCR (MS-PCR) and altered proliferation pathways.

Journal Articles

Whole body MRI at 7 tesla using a 1H/19F elliptic body coil with whole-body, fat-signal insensitive, three dimensional magnetic field shim algorithm

Leonard Liebes, Ray Lee, Songtao Liu, Michael Buckley, Howard Hochster, Oded Gonen

Mol Cancer Ther (2007) 6 (11_Supplement): B144.

Published: 01 November 2007

View article titled, Whole body MRI at 7 tesla using a 1H/19F elliptic body coil with whole-body, fat-signal insensitive, three dimensional magnetic field shim algorithm

Journal Articles

PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G₂-M Phase Arrest and Apoptosis

Yi-He Ling, Leonard Liebes, Bruce Ng, Michael Buckley, Peter J. Elliott, Julian Adams, Jian-Dong Jiang, Franco M. Muggia, Roman Perez-Soler

Mol Cancer Ther (2002) 1 (10): 841–849.

Published: 01 August 2002

View article titled, PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G<sub>2</sub>-M Phase Arrest and Apoptosis

NARROW

Bortezomib: Understanding the Mechanism of Action

Abstract B235: The utility of TRC093; A humanized monoclonal antibody directed against cleaved collagen in the detection of patients at risk of ovarian and breast cancer

Phase II trial of BAY 43-9006 (sorafenib-BAY) in metastatic melanoma (MM) including detection of BRAF mutations with mutant specific-PCR (MS-PCR) and altered proliferation pathways.

Whole body MRI at 7 tesla using a 1H/19F elliptic body coil with whole-body, fat-signal insensitive, three dimensional magnetic field shim algorithm

PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G₂-M Phase Arrest and Apoptosis

Email alerts

AACR Journals

Bortezomib: Understanding the Mechanism of Action

Abstract B235: The utility of TRC093; A humanized monoclonal antibody directed against cleaved collagen in the detection of patients at risk of ovarian and breast cancer

Phase II trial of BAY 43-9006 (sorafenib-BAY) in metastatic melanoma (MM) including detection of BRAF mutations with mutant specific-PCR (MS-PCR) and altered proliferation pathways.

Whole body MRI at 7 tesla using a 1H/19F elliptic body coil with whole-body, fat-signal insensitive, three dimensional magnetic field shim algorithm

PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G2-M Phase Arrest and Apoptosis

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G₂-M Phase Arrest and Apoptosis